Ipsen Advisor Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Sell
6,015
-86
-1% -$6.94K 0.3% 79
2026
Q1
$529K Buy
6,101
+149
+3% +$14.3K 0.37% 70
2025
Q4
$572K Buy
5,952
+101
+2% +$9.81K 0.41% 64
2025
Q3
$557K Sell
5,851
-110
-2% -$10.1K 0.4% 65
2025
Q2
$520K Buy
5,961
+169
+3% +$14.3K 0.4% 65
2025
Q1
$520K Buy
5,792
+45
+0.8% +$4.03K 0.45% 55
2024
Q4
$459K Buy
+5,747
New +$498K 0.39% 62
2022
Q4
$281K Buy
+3,621
New +$293K 0.32% 80

Other funds holding MDT

Ipsen Advisor Group's MDT Position: Q2 2026 in Review

Ipsen Advisor Group reduced its Medtronic (MDT) stake by 1.4% in Q2 2026, selling an estimated $6.94K and leaving 6,015 shares worth $471K. The position accounts for 0.3% of the portfolio, ranked #79.

Ipsen Advisor Group first reported a position in MDT in Q4 2022 and has held it in 8 quarters since. The position peaked at $572K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ipsen Advisor Group held 6,015 shares of Medtronic worth $471K as of Q2 2026.
  • Ipsen Advisor Group sold 86 Medtronic shares in Q2 2026, an estimated $6.94K.
  • Medtronic made up 0.3% of Ipsen Advisor Group's portfolio in Q2 2026, its #79 holding.
  • Ipsen Advisor Group first reported a position in Medtronic in Q4 2022 and has held it in 8 quarters since.
  • Ipsen Advisor Group's Medtronic position peaked at $572K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ipsen Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.